ArticleBMC bioinformatics2018

Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis.

Bin Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.